Adenocor

Adenocor is a pharmaceutical preparation containing Adenosine, used for specific cardiovascular conditions. This intravenous medication is manufactured by Sanofi-Aventis Zrt and is available in the EU market.

Adenocor is primarily used in medical settings to address certain heart rhythm disorders. It works by slowing electrical conduction in the heart, which can help restore normal heart rhythms. Adenosine is often administered intravenously to manage specific cardiac arrhythmias, providing rapid relief in controlled environments.

When administered, Adenocor may cause a brief slowing of the heart rate, which is a normal response to the medication. Some individuals might experience flushing, shortness of breath, or chest discomfort. These effects are typically short-lived and subside quickly.

Adenocor should be used under the supervision of a healthcare professional. It is important to inform your healthcare provider about any existing medical conditions or allergies before administration. This medication is intended for intravenous use and should be handled with care to avoid contamination.

Adenocor may interact with certain medications, including those that affect heart rhythm or blood pressure. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect the cardiovascular system should be avoided during treatment.